54 related articles for article (PubMed ID: 30214560)
1. EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.
Chakraborty S; Bhat AM; Mushtaq I; Luan H; Kalluchi A; Mirza S; Storck MD; Chaturvedi N; Lopez-Guerrero JA; Llombart-Bosch A; Machado I; Scotlandi K; Meza JL; Ghosal G; Coulter DW; Rowley JM; Band V; Mohapatra BC; Band H
bioRxiv; 2023 Mar; ():. PubMed ID: 36711452
[TBL] [Abstract][Full Text] [Related]
2. EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis.
Chakraborty S; Bhat AM; Mushtaq I; Luan H; Kalluchi A; Mirza S; Storck MD; Chaturvedi N; Lopez-Guerrero JA; Llombart-Bosch A; Machado I; Scotlandi K; Meza JL; Ghosal G; Coulter DW; Jordan Rowley M; Band V; Mohapatra BC; Band H
Commun Biol; 2023 Jul; 6(1):758. PubMed ID: 37474760
[TBL] [Abstract][Full Text] [Related]
3. A novel EHD1/CD44/Hippo/SP1 positive feedback loop potentiates stemness and metastasis in lung adenocarcinoma.
Liu Y; Song Y; Cao M; Fan W; Cui Y; Cui Y; Zhan Y; Gu R; Tian F; Zhang S; Cai L; Xing Y
Clin Transl Med; 2022 Apr; 12(4):e836. PubMed ID: 35485206
[TBL] [Abstract][Full Text] [Related]
4. Cellular functions and intrinsic attributes of the ATP-binding Eps15 homology domain-containing proteins.
Bhattacharyya S; Pucadyil TJ
Protein Sci; 2020 Jun; 29(6):1321-1330. PubMed ID: 32223019
[TBL] [Abstract][Full Text] [Related]
5. EHD1 and RUSC2 Control Basal Epidermal Growth Factor Receptor Cell Surface Expression and Recycling.
Tom EC; Mushtaq I; Mohapatra BC; Luan H; Bhat AM; Zutshi N; Chakraborty S; Islam N; Arya P; Bielecki TA; Iseka FM; Bhattacharyya S; Cypher LR; Goetz BT; Negi SK; Storck MD; Rana S; Barnekow A; Singh PK; Ying G; Guda C; Natarajan A; Band V; Band H
Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932478
[TBL] [Abstract][Full Text] [Related]
6. Targeting the IL-1β/EHD1/TUBB3 axis overcomes resistance to EGFR-TKI in NSCLC.
Huang J; Lan X; Wang T; Lu H; Cao M; Yan S; Cui Y; Jia D; Cai L; Xing Y
Oncogene; 2020 Feb; 39(8):1739-1755. PubMed ID: 31740781
[TBL] [Abstract][Full Text] [Related]
7. Molecular remodeling mechanisms of the neural somatodendritic compartment.
Moore FB; Baleja JD
Biochim Biophys Acta; 2012 Oct; 1823(10):1720-30. PubMed ID: 22705351
[TBL] [Abstract][Full Text] [Related]
8. Eps15 homology domain 1 promotes the evolution of papillary thyroid cancer by regulating endocytotic recycling of epidermal growth factor receptor.
Liu Y; Liang Y; Li M; Liu D; Tang J; Yang W; Tong D; Jin X
Oncol Lett; 2018 Oct; 16(4):4263-4270. PubMed ID: 30214560
[TBL] [Abstract][Full Text] [Related]
9. Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling.
Tong D; Liang YN; Stepanova AA; Liu Y; Li X; Wang L; Zhang F; Vasilyeva NV
Tumour Biol; 2017 Feb; 39(2):1010428317691010. PubMed ID: 28215104
[TBL] [Abstract][Full Text] [Related]
10. Increased EHD1 in non-small cell lung cancer predicts poor survival.
Lu H; Meng Q; Wen Y; Hu J; Zhao Y; Cai L
Thorac Cancer; 2013 Nov; 4(4):422-432. PubMed ID: 28920217
[TBL] [Abstract][Full Text] [Related]
11. Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.
Wang T; Xing Y; Meng Q; Lu H; Liu W; Yan S; Song Y; Xu X; Huang J; Cui Y; Jia D; Cai L
J Exp Clin Cancer Res; 2019 Apr; 38(1):174. PubMed ID: 31023336
[TBL] [Abstract][Full Text] [Related]
12. NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers.
Wang X; Yin H; Zhang H; Hu J; Lu H; Li C; Cao M; Yan S; Cai L
Cell Death Dis; 2018 Apr; 9(4):418. PubMed ID: 29549343
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 Inhibits Proliferation, Migration, and Invasion of Human Colorectal Cancer Cells by Suppressing Phosphorylation of Epidermal Growth Factor Receptor.
Yang J; Zhu T; Zhao R; Gao D; Cui Y; Wang K; Guo Y
Med Sci Monit; 2018 Jan; 24():332-341. PubMed ID: 29339715
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
